Advertisement

FDA Advisers Recommend Approving HPV DNA Test as Primary Cervical Screening Tool — Physician’s First Watch

Medical News |
March 14, 2014

FDA Advisers Recommend Approving HPV DNA Test as Primary Cervical Screening Tool

By Amy Orciari Herman

An FDA advisory panel voted unanimously on Wednesday to recommend approval of human papillomavirus DNA testing as an initial, standalone cervical screening test for women aged 25 and older, the New York Times reports.

The Times points out that if the FDA chooses to follow the panel's recommendation, then initial, solo HPV testing will become another screening option. Currently, U.S. guidelines recommend that women aged 21 through 29 undergo Pap testing every 3 years and those aged 30 to 65 undergo Pap testing alone every 3 years or cotesting with HPV DNA testing and Pap smear every 5 years.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement